139 related articles for article (PubMed ID: 12604558)
1. Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents.
Ednie LM; Rattan A; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2003 Mar; 47(3):1143-7. PubMed ID: 12604558
[TBL] [Abstract][Full Text] [Related]
2. Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents.
Ednie LM; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 2002 Jul; 50(1):101-5. PubMed ID: 12096013
[TBL] [Abstract][Full Text] [Related]
3. Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents.
Hoellman DB; Lin G; Ednie LM; Rattan A; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2003 Mar; 47(3):1148-50. PubMed ID: 12604559
[TBL] [Abstract][Full Text] [Related]
4. Anti-anaerobic potential of ranbezolid: insight into its mechanism of action against Bacteroides fragilis.
Mathur T; Kalia V; Barman TK; Singhal S; Khan S; Upadhyay DJ; Rattan A; Raj VS
Int J Antimicrob Agents; 2013 Jan; 41(1):36-40. PubMed ID: 23142085
[TBL] [Abstract][Full Text] [Related]
5. Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species.
Credito KL; Appelbaum PC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4430-4. PubMed ID: 15504874
[TBL] [Abstract][Full Text] [Related]
6. The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
Watt B; Naden M
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():119-24. PubMed ID: 2808203
[TBL] [Abstract][Full Text] [Related]
7. Effect of oxazolidinone, RBx 7644 (ranbezolid), on inhibition of staphylococcal adherence to plastic surfaces.
Mathur T; Singhal S; Khan S; Bhateja P; Pandya M; Rattan A; Bhatnagar PK; Upadhyay DJ; Fatma T
J Chemother; 2008 Aug; 20(4):420-7. PubMed ID: 18676219
[TBL] [Abstract][Full Text] [Related]
8. Activity of linezolid against anaerobic bacteria.
Behra-Miellet J; Calvet L; Dubreuil L
Int J Antimicrob Agents; 2003 Jul; 22(1):28-34. PubMed ID: 12842325
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and SAR of novel oxazolidinones: discovery of ranbezolid.
Das B; Rudra S; Yadav A; Ray A; Rao AV; Srinivas AS; Soni A; Saini S; Shukla S; Pandya M; Bhateja P; Malhotra S; Mathur T; Arora SK; Rattan A; Mehta A
Bioorg Med Chem Lett; 2005 Oct; 15(19):4261-7. PubMed ID: 16054358
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of RBx 7644 (ranbezolid) on biofilm producing bacteria.
Mathur T; Bhateja P; Pandya M; Fatma T; Rattan A
Int J Antimicrob Agents; 2004 Oct; 24(4):369-73. PubMed ID: 15380263
[TBL] [Abstract][Full Text] [Related]
11. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
Credito KL; Ednie LM; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2027-31. PubMed ID: 10428930
[TBL] [Abstract][Full Text] [Related]
12. The in-vitro activity of linezolid (U-100766) and tentative breakpoints.
Wise R; Andrews JM; Boswell FJ; Ashby JP
J Antimicrob Chemother; 1998 Dec; 42(6):721-8. PubMed ID: 10052894
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
Antimicrob Agents Chemother; 2004 Jun; 48(6):2149-52. PubMed ID: 15155214
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections.
Odou MF; Muller C; Calvet L; Dubreuil L
J Antimicrob Chemother; 2007 Apr; 59(4):646-51. PubMed ID: 17350985
[TBL] [Abstract][Full Text] [Related]
15. Antianaerobic activity of a novel fluoroquinolone, WCK 771, compared to those of nine other agents.
Peric M; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Aug; 48(8):3188-92. PubMed ID: 15273148
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of gatifloxacin, a new fluoroquinolone, against 204 anaerobes compared to seven other compounds.
Dubreuil L; Behra-Miellet J; Neut C; Calvet L
Clin Microbiol Infect; 2003 Nov; 9(11):1133-8. PubMed ID: 14616733
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomycetes, and lactobacilli.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT; Bryskier A
Antimicrob Agents Chemother; 2005 Jan; 49(1):408-13. PubMed ID: 15616322
[TBL] [Abstract][Full Text] [Related]
18. Mode of action of Ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomes.
Kalia V; Miglani R; Purnapatre KP; Mathur T; Singhal S; Khan S; Voleti SR; Upadhyay DJ; Saini KS; Rattan A; Raj VS
Antimicrob Agents Chemother; 2009 Apr; 53(4):1427-33. PubMed ID: 19075051
[TBL] [Abstract][Full Text] [Related]
19. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
[TBL] [Abstract][Full Text] [Related]
20. Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.
Lundstrom TS; Sobel JD
Infect Dis Clin North Am; 2000 Jun; 14(2):463-74. PubMed ID: 10829266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
